Our in-depth mechanistic study of the synthetic lethality of GSK3β-FHIT in lung cancer established the following model: (1) FHIT loss activates the DNA damage response, particularly the HRR repair pathway, following increased DNA damage. Here, GSK3B is linked to lung cancer.